A Case for Less Intensive Blood Pressure Control: It Matters to Achieve Target Blood Pressure Early and Sustained Below 140/90mmHg

Although high blood pressure (BP) is the leading risk factors for cardiovascular (CV) disease, the optimal BP treatment target in order to reduce CV risk is unclear in the aftermath of the SPRINT study. The aim of this review is to assess large, randomized, and controlled trials on BP targets, as well as review selected observational analyses from other large randomized BP trials in order to evaluate the benefit of intense vs. standard BP control. None of the studies, except SPRINT, favored intense BP treatment.

Source: Progress in Cardiovascular Diseases - September 8, 2016 Category: Cardiology Authors: Julian E. Mariampillai, Per Anders Esk ås, Sondre Heimark, Sverre E. Kjeldsen, Krzysztof Narkiewicz, Giuseppe Mancia Source Type: research